Form 4: Zai Lab Executive Rafael Amado Acquires Stock Options and Restricted Share Units
SEC Form 4 Filing
Rafael Amado, a Zai Lab executive, reports the acquisition of stock options and restricted share units in the company.
Summary
- On March 12, 2025, Rafael Amado, President, Head of Global Oncology Research and Development at Zai Lab Ltd, acquired stock options for 65,523 American Depositary Shares (ADS) at an exercise price of $35.55.
- These options vest in equal annual installments over four years, starting March 12, 2026, contingent upon continuous service.
- Amado also acquired 21,294 Restricted Share Units (RSUs), each representing a contingent right to receive one ADS.
- These RSUs also vest in equal annual installments over four years, beginning March 12, 2026, subject to continuous service, with vested shares delivered as ADSs.
- Following these transactions, Amado directly owns 65,523 stock options and 21,294 RSUs.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices and aligns executive interests with shareholder value. The vesting schedule incentivizes continued service.
Positives
- The acquisition of stock options and RSUs by a key executive signals confidence in the company's future performance.
Future Outlook
The vesting schedules for the stock options and RSUs are contingent upon continuous service, incentivizing the executive to remain with the company.
Industry Context
Stock option and RSU grants are common practices in the biotech industry to attract and retain key talent, aligning their interests with those of the shareholders.
Stakeholder Impact
- Shareholders may view this as a positive sign, indicating that the company is incentivizing its executives to perform well.
- Employees may see this as a positive sign, indicating that the company is investing in its employees.
Key Dates
| Date | Description |
|---|---|
| 03/12/2025 | Date of transaction: acquisition of stock options and RSUs. |
| 03/12/2026 | First vesting date for both stock options and RSUs. |
| 03/12/2035 | Expiration date for the stock options. |
| 03/14/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.